FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Rossana Berardi

Research Profile

Procedures

Chemicals & Drugs

Disorders

Concepts & Ideas

Co-author Network

Publications

TOP 3
Matteo Santoni; Mimma Rizzo; Rossana Berardi; Luciano Burattini; Giacomo Carteni; Stefano Cascinu
Novel Agents, Combinations and Sequences for the Treatment of Advanced Renal Cell Carcinoma: When is the Revolution Coming?
Rossana Berardi; Miriam Caramanti; Zelmira Ballatore; Mariagrazia De Lisa; Paola Mazzanti; Francesca Morgese; Azzurra Onofri; Silvia Pagliaretta; Chiara Pierantoni; Mirco Pistelli; Silvia Rinaldi; Matteo Santoni; Agnese Savini; Stefano Cascinu
Role of maspin in cancer.
Rossana Berardi; Alen Federici; Federico Mocchegiani; Francesca Morgese; Daniele Nicolini; Azzurra Onofri; Chiara Pierantoni; Andrea Risaliti; Marco Vivarelli; Stefano Cascinu
Resected biliary tract cancers: a novel clinical-pathological score correlates with global outcome.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Rossana Berardi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Matteo Santoni; Mimma Rizzo; Rossana Berardi; Luciano Burattini; Giacomo Carteni; Stefano Cascinu
Novel Agents, Combinations and Sequences for the Treatment of Advanced Renal Cell Carcinoma: When is the Revolution Coming?
Current cancer drug targets 2013;13(3):313-25.
2013: Rossana Berardi; Miriam Caramanti; Zelmira Ballatore; Mariagrazia De Lisa; Paola Mazzanti; Francesca Morgese; Azzurra Onofri; Silvia Pagliaretta; Chiara Pierantoni; Mirco Pistelli; Silvia Rinaldi; Matteo Santoni; Agnese Savini; Stefano Cascinu
Role of maspin in cancer.
Clinical and translational medicine 2013;2(1):8.
2013: Rossana Berardi; Alen Federici; Federico Mocchegiani; Francesca Morgese; Daniele Nicolini; Azzurra Onofri; Chiara Pierantoni; Andrea Risaliti; Marco Vivarelli; Stefano Cascinu
Resected biliary tract cancers: a novel clinical-pathological score correlates with global outcome.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2013;45(1):70-4.
2012: Rossana Berardi; Tommasina Biscotti; Italo Bearzi; Mario Guerrieri; Elena Maccaroni; Alessandra Mandolesi; Giovanna Mantello; Cristina Marmorale; Azzurra Onofri; Chiara Pierantoni; Walter Siquini; Stefano Cascinu
Nuclear factor-κB predicts outcome in locally advanced rectal cancer patients receiving neoadjuvant radio-chemotherapy.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2012;44(7):617-22.
2012: Rossana Berardi; Alessandro Brunelli; Italo Bearzi; Stefano Gasparini; Paola Mazzanti; Azzurra Onofri; Alessandra Pagliacci; Chiara Pierantoni; Eleonora Pisa; Armando Sabbatini; Alfredo Santinelli; Daniela Stramazzotti; L Zuccatosta; Stefano Cascinu
Maspin expression is a favorable prognostic factor in non-small cell lung cancer.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 2012;34(2):72-8.
2012: Anna Campanati; Stefano Cascinu; I Conte; K Giuliodori; F Marcucci; E Molinelli; A Onofri; Chiara Pierantoni; Rossana Berardi; Annamaria Offidani
A novel approach to manage skin toxicity caused by therapeutic agents targeting epidermal growth factor receptor.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(4):1081-2.
2011: Rossana Berardi; S Miseria; Stefano Cascinu
Professional failure: how do oncologists feel it?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(12):2696-7.
2011: Rossana Berardi; Alessandro Brunelli; Stefano Gasparini; Paola Mazzanti; Azzurra Onofri; Chiara Pierantoni; Eleonora Pisa; Armando Sabbatini; Alfredo Santinelli; MARIO SCARTOZZI; Daniela Stramazzotti; L Zuccatosta; Stefano Cascinu
Epidermal growth factor receptor status in stages of resected non-small cell lung cancer: implications for treatment with epidermal growth factor receptor inhibitors.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 2011;33(4):196-204.
2011: Stefano Cascinu; Francesco Ferraù; Eva Galizia; Roberto Labianca; Gabriele Luppi; Francesca Pucci; Rossana Berardi; Giordano Domenico Beretta; Rosa Rita Silva; MARIO SCARTOZZI
Pegylated liposomal doxorubicin, 5-fluorouracil and cisplatin versus mitomycin-C, 5-fluorouracil and cisplatin for advanced gastric cancer: a randomized phase II trial.
Cancer chemotherapy and pharmacology 2011;68(1):37-43.
2011: Cristina Marmorale; Pierpaolo Stortoni; Walter Siquini; Mario Scartozzi; Rossana Berardi; Alessandra Mandolesi; Italo Bearzi; Aroldo Fianchini
Adenocarcinoma arising from ileoanal J-pouch mucosa: an announced event?
Inflammatory bowel diseases 2011;17(6):E57-8.
2011: Luca Faloppi; MARIO SCARTOZZI; Elena Maccaroni; Marzia Di Pietro Paolo; Rossana Berardi; Michela Del Prete; Stefano Cascinu
Evolving strategies for the treatment of hepatocellular carcinoma: from clinical-guided to molecularly-tailored therapeutic options.
Cancer treatment reviews 2011;37(3):169-77.
2011: MARIO SCARTOZZI; C Loretelli; Italo Bearzi; Alessandra Mandolesi; Eva Galizia; A Onofri; M Pistelli; A Bittoni; Rossana Berardi; Stefano Cascinu
Allele polymorphisms of tumor integrins correlate with peritoneal carcinosis capability of gastric cancer cells in radically resected patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(4):897-902.
2011: MARIO SCARTOZZI; Walter Siquini; Eva Galizia; Pierpaolo Stortoni; Cristina Marmorale; Rossana Berardi; Aroldo Fianchini; Stefano Cascinu
The timing of surgery for resectable metachronous liver metastases from colorectal cancer: Better sooner than later? A retrospective analysis.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2011;43(3):194-8.
2011: MARIO SCARTOZZI; Maristella Bianconi; Elena Maccaroni; Riccardo Giampieri; Michela Del Prete; Rossana Berardi; Stefano Cascinu
State of the art and future perspectives for the use of insulin-like growth factor receptor 1 (IGF-1R) targeted treatment strategies in solid tumors.
Discovery medicine 2011;11(57):144-53.
2011: MARIO SCARTOZZI; Elena Maccaroni; Riccardo Giampieri; Mirco Pistelli; Alessandro Bittoni; Michela Del Prete; Rossana Berardi; Stefano Cascinu
5-Fluorouracil pharmacogenomics: still rocking after all these years?
Pharmacogenomics 2011;12(2):251-65.
2011: MARIO SCARTOZZI; Alessandra Mandolesi; Riccardo Giampieri; Alessandro Bittoni; Chiara Pierantoni; alberto zaniboni; Eva Galizia; Lucio Giustini; Rosa Rita Silva; Renato Bisonni; Rossana Berardi; Tommasina Biscotti; Simona Biagetti; Italo Bearzi; Stefano Cascinu
The role of HER-3 expression in the prediction of clinical outcome for advanced colorectal cancer patients receiving irinotecan and cetuximab.
The oncologist 2011;16(1):53-60.
2010: MARIO SCARTOZZI; Alessandra Mandolesi; Riccardo Giampieri; Chiara Pierantoni; Fotios Loupakis; alberto zaniboni; Eva Galizia; Lucio Giustini; Rosa Rita Silva; Renato Bisonni; Rossana Berardi; Simona Biagetti; Stefano Menzo; Alfredo Falcone; Italo Bearzi; Stefano Cascinu
Insulin-like growth factor 1 expression correlates with clinical outcome in K-RAS wild type colorectal cancer patients treated with cetuximab and irinotecan.
International journal of cancer. Journal international du cancer 2010;127(8):1941-7.
2010: MARIO SCARTOZZI; Maristella Bianconi; Elena Maccaroni; Riccardo Giampieri; Rossana Berardi; Stefano Cascinu
Dalotuzumab, a recombinant humanized mAb targeted against IGFR1 for the treatment of cancer.
Current opinion in molecular therapeutics 2010;12(3):361-71.
2010: MARIO SCARTOZZI; Paola Mazzanti; Riccardo Giampieri; Rossana Berardi; Eva Galizia; S Gasparini; L Zuccatosta; Stefano Cascinu
Clinical predictive factors for advanced non-small cell lung cancer (NSCLC) patients receiving third-line therapy: Selecting the unselectable?
Lung cancer (Amsterdam, Netherlands) 2010;68(3):433-7.
2010: MARIO SCARTOZZI; Mirco Pistelli; Alessandro Bittoni; Riccardo Giampieri; Eva Galizia; Rossana Berardi; Luca Faloppi; Michela Del Prete; Stefano Cascinu
Novel perspectives for the treatment of gastric cancer: from a global approach to a personalized strategy.
Current oncology reports 2010;12(3):175-85.
2010: A Bittoni; E Maccaroni; MARIO SCARTOZZI; Rossana Berardi; Stefano Cascinu
Chemotherapy for locally advanced and metastatic gastric cancer: state of the art and future perspectives.
European review for medical and pharmacological sciences 2010;14(4):309-14.
2010: MARIO SCARTOZZI; Gianluca Svegliati Baroni; Luca Faloppi; Marzia Di Pietro Paolo; Chiara Pierantoni; R Candelari; Rossana Berardi; Stefania Antognoli; Cinzia Mincarelli; Andrea Risaliti; Cristina Marmorale; Ettore Antico; Antonio Benedetti; Stefano Cascinu
Trans-arterial chemo-embolization (TACE), with either lipiodol (traditional TACE) or drug-eluting microspheres (precision TACE, pTACE) in the treatment of hepatocellular carcinoma: efficacy and safety results from a large mono-institutional analysis.
Journal of experimental & clinical cancer research : CR 2010;29():164.
2010: Rossana Berardi; Azzurra Onofri; Mirco Pistelli; Elena Maccaroni; MARIO SCARTOZZI; Chiara Pierantoni; Stefano Cascinu
Panitumumab: the evidence for its use in the treatment of metastatic colorectal cancer.
Core evidence 2010;5():61-76.
2009: MARIO SCARTOZZI; Italo Bearzi; Alessandra Mandolesi; Eva Galizia; Chiara Pierantoni; Fotios Loupakis; Rossana Berardi; alberto zaniboni; Antonello Quadri; Fausto Zorzi; Simona Biagetti; Cristian Loretelli; Tommasina Biscotti; Roberto Labianca; Gianluca Masi; Alfredo Falcone; Stefano Cascinu
Epidermal growth factor receptor gene promoter methylation in primary colorectal tumors and corresponding metastatic sites: a new perspective for an "old" therapeutic target.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 2009;31(6):417-23.
2009: Rossana Berardi; Giovanna Mantello; MARIO SCARTOZZI; Stefano Del Prete; Gabriele Luppi; Roberto Martinelli; Marco Fumagalli; Filippo Grillo Ruggieri; Italo Bearzi; Alessandra Mandolesi; Cristina Marmorale; Stefano Cascinu
Locally advanced rectal cancer patients receiving radio-chemotherapy: a novel clinical-pathologic score correlates with global outcome.
International journal of radiation oncology, biology, physics 2009;75(5):1437-43.
2009: Rossana Berardi; Elena Maccaroni; Azzurra Onofri; Riccardo Giampieri; Mirco Pistelli; Alessandro Bittoni; MARIO SCARTOZZI; Chiara Pierantoni; Alessandra Mandolesi; Italo Bearzi; Stefano Cascinu
Locally advanced rectal cancer: from molecular profiling to clinical practice. A literature review: Part 2.
Expert opinion on pharmacotherapy 2009;10(15):2467-78.
2009: Rossana Berardi; Elena Maccaroni; Azzurra Onofri; Riccardo Giampieri; Alessandro Bittoni; Mirco Pistelli; MARIO SCARTOZZI; Chiara Pierantoni; Maristella Bianconi; Stefano Cascinu
Multidisciplinary treatment of locally advanced rectal cancer: a literature review. Part 1.
Expert opinion on pharmacotherapy 2009;10(14):2245-58.
2009: MARIO SCARTOZZI; Alessandro Bittoni; Mirco Pistelli; Eva Galizia; Rossana Berardi; Riccardo Giampieri; Luca Faloppi; Stefano Cascinu
Toward molecularly selected chemotherapy for advanced gastric cancer: state of the art and future perspectives.
Cancer treatment reviews 2009;35(5):451-62.
2009: Rossana Berardi; Lorena Verdecchia; Marzia Di Pietro Paolo; Riccardo Giampieri; MARIO SCARTOZZI; Chiara Pierantoni; Maristella Bianconi; Paola Mazzanti; Stefano Cascinu
Women and lung cancer: clinical and molecular profiling as a determinate for treatment decisions: a literature review.
Critical reviews in oncology/hematology 2009;69(3):223-36.
2009: MARIO SCARTOZZI; Italo Bearzi; Alessandra Mandolesi; Chiara Pierantoni; Fotios Loupakis; alberto zaniboni; Francesca Negri; Antonello Quadri; Fausto Zorzi; Eva Galizia; Rossana Berardi; Tommasina Biscotti; Roberto Labianca; Gianluca Masi; Alfredo Falcone; Stefano Cascinu
Epidermal Growth Factor Receptor (EGFR) gene copy number (GCN) correlates with clinical activity of irinotecan-cetuximab in K-RAS wild-type colorectal cancer: a fluorescence in situ (FISH) and chromogenic in situ hybridization (CISH) analysis.
BMC cancer 2009;9():303.
2008: Chiara Pierantoni; Alessandra Pagliacci; MARIO SCARTOZZI; Rossana Berardi; Maristella Bianconi; Stefano Cascinu
Pancreatic cancer: progress in cancer therapy.
Critical reviews in oncology/hematology 2008;67(1):27-38.
2008: Stefano Cascinu; Rossana Berardi; Stefania Salvagni; Giordano D Beretta; Vincenzo Catalano; Francesca Pucci; Alberto Sobrero; Pierosandro Tagliaferri; Roberto Labianca; MARIO SCARTOZZI; F Crocicchio; E Mari; Andrea Ardizzoni
A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activation.
British journal of cancer 2008;98(1):71-6.
2008: Stefano Cascinu; Rossana Berardi; Roberto Labianca; Salvatore Siena; Alfredo Falcone; Enrico Aitini; Sandro Barni; Francesco Di Costanzo; Elisa Dapretto; Giuseppe Tonini; Chiara Pierantoni; Salvatore Artale; Silvia Rota; Irene Floriani; MARIO SCARTOZZI; alberto zaniboni
Cetuximab plus gemcitabine and cisplatin compared with gemcitabine and cisplatin alone in patients with advanced pancreatic cancer: a randomised, multicentre, phase II trial.
The lancet oncology 2008;9(1):39-44.
2007: Stefano Cascinu; MARIO SCARTOZZI; Giovanna Carbonari; Chiara Pierantoni; Lorena Verdecchia; Cinzia Mariani; Michela Squadroni; Stefania Antognoli; Rosa Rita Silva; Riccardo Giampieri; Rossana Berardi
COX-2 and NF-KB overexpression is common in pancreatic cancer but does not predict for COX-2 inhibitors activity in combination with gemcitabine and oxaliplatin.
American journal of clinical oncology 2007;30(5):526-30.
2007: Filippo Grillo Ruggieri; Giovanna Mantello; Rossana Berardi; Massimo Cardinali; Francesco Fenu; Giuseppina Iovini; Maria Montisci; Letizia Fabbietti; Cristina Marmorale; Mario Guerrieri; Vittorio Saba; Italo Bearzi; Rodolfo Mattioli; Maurizio Bonsignori; Stefano Cascinu
Mucinous rectal adenocarcinoma can be associated to tumor downstaging after preoperative chemoradiotherapy.
Diseases of the colon and rectum 2007;50(10):1594-603.
2007: MARIO SCARTOZZI; Italo Bearzi; Chiara Pierantoni; Alessandra Mandolesi; Fotios Loupakis; alberto zaniboni; Vincenzo Catalano; Antonello Quadri; Fausto Zorzi; Rossana Berardi; Tommasina Biscotti; Roberto Labianca; Alfredo Falcone; Stefano Cascinu
Nuclear factor-kB tumor expression predicts response and survival in irinotecan-refractory metastatic colorectal cancer treated with cetuximab-irinotecan therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(25):3930-5.
2007: MARIO SCARTOZZI; Italo Bearzi; Rossana Berardi; Alessandra Mandolesi; Chiara Pierantoni; Stefano Cascinu
Epidermal growth factor receptor (EGFR) downstream signalling pathway in primary colorectal tumours and related metastatic sites: optimising EGFR-targeted treatment options.
British journal of cancer 2007;97(1):92-7.
2007: MARIO SCARTOZZI; Eva Galizia; Lorena Verdecchia; Rossana Berardi; Stefania Antognoli; Silvia Chiorrini; Stefano Cascinu
Chemotherapy for advanced gastric cancer: across the years for a standard of care.
Expert opinion on pharmacotherapy 2007;8(6):797-808.
2006: Rossana Berardi; Chiara Braconi; Giovanna Mantello; MARIO SCARTOZZI; S Del Prete; Gabriele Luppi; R Martinelli; M Fumagalli; Gianluca Valeri; Italo Bearzi; C Marmovale; F Grillö-Ruggieri; Stefano Cascinu
Anemia may influence the outcome of patients undergoing neo-adjuvant treatment of rectal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(11):1661-4.
2006: MARIO SCARTOZZI; Alfredo Falcone; Francesca Pucci; Chiara Braconi; Chiara Pierantoni; Luigi Cavanna; Vittorio Franciosi; Rossana Berardi; Giordano D Beretta; Gianluca Masi; Giacomo Allegrini; alberto zaniboni; Roberto Labianca; Stefano Cascinu
Capecitabine and mitomycin C may be an effective treatment option for third-line chemotherapy in advanced colorectal cancer.
Tumori 2006;92(5):384-8.
2006: MARIO SCARTOZZI; Eva Galizia; Lorena Verdecchia; Rossana Berardi; Graziano Francesco; Vincenzo Catalano; Paolo Giordani; Davide Mari; Rosa Rita Silva; Cristina Marmorale; C Zingaretti; Stefano Cascinu
Lymphatic, blood vessel and perineural invasion identifies early-stage high-risk radically resected gastric cancer patients.
British journal of cancer 2006;95(4):445-9.
2006: Rossana Berardi; Berardi Rossana; MARIO SCARTOZZI; Scartozzi Mario; Federica Freddari; Freddari Federica; Michela Squadroni; Squadroni Michela; Alfredo Santinelli; Santinelli Alfredo; Italo Bearzi; Bearzi Italo; Guidalberto Fabris; Fabris Guidalberto; Stefano Cascinu; Cascinu Stefano
Biliary tract cancers: molecular profiling as a tool for treatment decisions. A literature review.
Cancer treatment reviews 2006;32(5):333-47.
2006: MARIO SCARTOZZI; Vittorio Franciosi; Nicoletta Campanini; Giovanni Benedetti; Fausto Barbieri; Giulio Rossi; Rossana Berardi; Roberta Camisa; Rosa Rita Silva; Alfredo Santinelli; Andrea Ardizzoni; Lucio Crinò; Guido Rindi; Stefano Cascinu
Mismatch repair system (MMR) status correlates with response and survival in non-small cell lung cancer (NSCLC) patients.
Lung cancer (Amsterdam, Netherlands) 2006;53(1):103-9.
2006: Stefano Cascinu; Lorena Verdecchia; N Valeri; Rossana Berardi; MARIO SCARTOZZI
New target therapies in advanced pancreatic cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17 Suppl 5():v148-52.
2006: MARIO SCARTOZZI; Chiara Pierantoni; Rossana Berardi; Stefania Antognoli; Italo Bearzi; Stefano Cascinu
Epidermal growth factor receptor: a promising therapeutic target for colorectal cancer.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 2006;28(2):61-8.
2006: MARIO SCARTOZZI; Chiara Pierantoni; Rossana Berardi; Michela Squadroni; Stefano Cascinu
Anti-EGFR strategies as an incremental step for the treatment of colorectal cancer patients: moving from scientific evidence to clinical practice.
Expert opinion on therapeutic targets 2006;10(2):281-7.
2005: Giovanna Mantello; Rossana Berardi; Massimo Cardinali; Letizia Fabbietti; Francesco Fenu; Maria Montisci; G Iovini; Stefano Delprete; Rodolfo Mattioli; Stefano Cascinu; Filippo Grillo Ruggieri
Feasibility of preoperative chemoradiation in rectal cancer patients aged 70 and older.
Journal of experimental & clinical cancer research : CR 2005;24(4):541-6.
2005: Rossana Berardi; G Grilli; E Romagnoli; T Saladino; Federica Freddari; T Tamburrano; Eva Galizia; G Carbonari; C Mariani; Chiara Braconi; Chiara Pierantoni; Nicola Battelli; MARIO SCARTOZZI; Stefano Cascinu
[Paraneoplastic syndromes: a review].
La Clinica terapeutica 2005;156(6):281-8.
2005: Rossana Berardi; Tiziana Saladino; Davide Mari; Rosa Rita Silva; MARIO SCARTOZZI; Lorena Verdecchia; Azzurra Onofri; Stefano Cascinu
Elderly patients with advanced colorectal cancer: tolerability and activity of chemotherapy.
Tumori 2005;91(6):463-6.
2005: Rossana Berardi; Alessandro Brunelli; T Tamburrano; Lorena Verdecchia; A Onofri; L Zuccatosta; S Gasparini; Alfredo Santinelli; MARIO SCARTOZZI; Gianluca Valeri; Andrea Giovagnoni; Gian Marco Giuseppetti; Guidalberto Fabris; Cristina Marmorale; Aroldo Fianchini; Stefano Cascinu
Perioperative anemia and blood transfusions as prognostic factors in patients undergoing resection for non-small cell lung cancers.
Lung cancer (Amsterdam, Netherlands) 2005;49(3):371-6.
2005: MARIO SCARTOZZI; Rossana Berardi; Chiara Pierantoni; Stefano Cascinu
Pre-operative treatment modalities in gastric cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16 Suppl 4():iv106-109.
2005: Graziano Francesco; Annamaria Ruzzo; Daniele Santini; Bostjan Humar; Giuseppe Tonini; Vincenzo Catalano; Rossana Berardi; Francesca Pizzagalli; Federica Arduini; Italo Bearzi; MARIO SCARTOZZI; Stefano Cascinu; Enrica Testa; Rita Ficarelli; Mauro Magnani
Prognostic role of interleukin-1beta gene and interleukin-1 receptor antagonist gene polymorphisms in patients with advanced gastric cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(10):2339-45.
2005: MARIO SCARTOZZI; Eva Galizia; Graziano Francesco; Vincenzo Catalano; Rossana Berardi; Anna Maria Baldelli; Enrica Testa; Davide Mari; Rosa Rita Silva; Stefano Cascinu
Over-DI dissection may question the value of radiotherapy as a part of an adjuvant programme in high-risk radically resected gastric cancer patients.
British journal of cancer 2005;92(6):1051-4.
2005: MARIO SCARTOZZI; Alberto Sobrero; G Gasparini; Rossana Berardi; Vincenzo Catalano; Graziano Francesco; Sandro Barni; alberto zaniboni; Giordano D Beretta; Roberto Labianca; Stefano Cascinu
The role of 5-fluorouracil (5-FU) reintroduction with irinotecan or oxaliplatin in truly 5-FU-refractory advanced colorectal cancer patients.
Oncology 2005;68(2-3):212-6.
2005: Rossana Berardi; Lorena Verdecchia; MARIO SCARTOZZI; Stefano Cascinu
New frontiers in the neoadjuvant therapy of pancreatic adenocarcinoma: apart from therapeutical protocols.
JOP : Journal of the pancreas 2005;6(1 Suppl):118-21.
2004: MARIO SCARTOZZI; Italo Bearzi; Rossana Berardi; Alessandra Mandolesi; Guidalberto Fabris; Stefano Cascinu
Epidermal growth factor receptor (EGFR) status in primary colorectal tumors does not correlate with EGFR expression in related metastatic sites: implications for treatment with EGFR-targeted monoclonal antibodies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(23):4772-8.
2004: Eva Galizia; Rossana Berardi; MARIO SCARTOZZI; Stefano Cascinu
A cost-benefit analysis of chemotherapy for gastric cancer.
Expert opinion on pharmacotherapy 2004;5(10):2109-14.
2004: MARIO SCARTOZZI; Eva Galizia; Federica Freddari; Rossana Berardi; Riccardo Cellerino; Stefano Cascinu
Molecular biology of sporadic gastric cancer: prognostic indicators and novel therapeutic approaches.
Cancer treatment reviews 2004;30(5):451-9.
2004: Stefano Cascinu; Rossana Berardi
[The DUR studies: colon cancer adjuvants].
I supplementi di Tumori : official journal of Società italiana di cancerologia ... [et al.] 2004;3(4):S88.
2004: Graziano Francesco; Alessandra Mandolesi; Annamaria Ruzzo; Italo Bearzi; Enrica Testa; Federica Arduini; Rosarita Silva; Pietro Muretto; Davide Mari; Rossana Berardi; MARIO SCARTOZZI; Vittorio Lai; Stefano Cascinu; Mauro Magnani
Predictive and prognostic role of E-cadherin protein expression in patients with advanced gastric carcinomas treated with palliative chemotherapy.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2004;25(3):106-10.
2004: Stefano Cascinu; MARIO SCARTOZZI; Roberto Labianca; Vincenzo Catalano; Rosa Rita Silva; Sandro Barni; alberto zaniboni; A D'Angelo; Stefania Salvagni; Giancarlo Martignoni; Giordano D Beretta; Graziano Francesco; Rossana Berardi; Vittorio Franciosi
High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).
British journal of cancer 2004;90(8):1521-5.
2004: Rossana Berardi; MARIO SCARTOZZI; Emanuela Romagnoli; Stefania Antognoli; Stefano Cascinu
Gastric cancer treatment: a systematic review.
Oncology reports 2004;11(4):911-6.
2004: Federica Freddari; Rossana Berardi; MARIO SCARTOZZI; Stefano Cascinu
[Non-small cell lung carcinoma: pathology, biology and prognosis].
I supplementi di Tumori : official journal of Società italiana di cancerologia ... [et al.] 2004;3(2):S3-4.
2003: Rossana Berardi; Andrea Piga; Franca Pulita; Emanuela Romagnoli; Debora Pietroselli; Flavia Carle; Stefano Cascinu; Riccardo Cellerino
Effective prevention of 5-fluorouracil-induced superficial phlebitis by ketoprofen lysine salt gel.
The American journal of medicine 2003;115(5):415-7.
2003: Rossana Berardi; MARIO SCARTOZZI; Eva Galizia; Stefano Cascinu
Adjuvant chemotherapy in gastric cancer. The Italian experience and review of the literature.
I supplementi di Tumori : official journal of Società italiana di cancerologia ... [et al.] 2003;2(5):S45-7.
2003: Rossana Berardi; Luciano Latini; Alfredo Santinelli; N Herber; S Baldassarre; MARIO SCARTOZZI; Riccardo Cellerino
Mucocele-like tumour of the breast.
Journal of experimental & clinical cancer research : CR 2003;22(2):329-32.
2003: MARIO SCARTOZZI; M De Nictolis; Eva Galizia; P Carassai; Francesca Bianchi; Rossana Berardi; Rosaria Gesuita; Andrea Piga; Riccardo Cellerino; Emilio Porfiri
Loss of hMLH1 expression correlates with improved survival in stage III-IV ovarian cancer patients.
European journal of cancer (Oxford, England : 1990) 2003;39(8):1144-9.
2003: Rossana Berardi; Emilio Porfiri; MARIO SCARTOZZI; Paolo Lippe; Rosa Rita Silva; D Nacciarriti; Ettore Tito Menichetti; Diego Tummarello; Flavia Carle; Andrea Piga; Riccardo Cellerino
Elderly patients with advanced non-small cell lung cancer. A pase II study with weekly cisplatin and gemcitabine.
Oncology 2003;65(3):198-203.
2003: Paolo Lippe; Rossana Berardi; Claudia Cappelletti; Cristian Massacesi; Rodolfo Mattioli; Luciano Latini; Riccardo Cellerino
Desmoplastic small round cell tumour: a description of two cases and review of the literature.
Oncology 2003;64(1):14-7.
2001: Paolo Lippe; Rossana Berardi; Luciano Latini; Raffaella Bracci; Riccardo Cellerino
Severe prognosis of signet-ring cell adenocarcinoma occurring in Meckel's diverticulum.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(2):277.
2000: Paolo Lippe; Rosa R Silva; Luciano Giuliodori; M A Cancellieri; Nicola Battelli; Cristian Massacesi; Rossana Berardi; Renato Bisonni; Rosaria Gesuita; Riccardo Cellerino
Advanced non-small cell lung cancer in the elderly: effective and well tolerated weekly gemcitabine and cisplatin regimen. A pilot study.
Minerva medica 2000;91(3-4):53-7.